Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat Monotherapy in HER2-negative Advanced Breast Cancer
NCT00777049Phase 2Completed
- Sponsor
- Translational Research In Oncology
- Start
- Feb 2009
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of panobinostat in breast cancer (2 arms), sponsored by Translational Research In Oncology. Primary endpoint: Objective Response Rate. Started Feb 2009; status: completed.
02
Drugs
panobinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00777049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00777049.